Brit Mollenhauer

Brit Mollenhauer

Professor Brit Mollenhauer is a professor in the Department of Neurology at University Medical Center Göttingen and chief physician at Paracelsus-Elena-Clinic Kassel, both in Germany.

She has received her medical degree and completed her residency training in neurology at University Medical Center Göttingen. She was a research fellow in neurology at Harvard Medical School and Brigham and Women’s Hospital, both in Boston, Massachusetts. At Harvard, she worked on developing biomarkers and studied α-synuclein as a biomarker in biological fluids.

Professor Mollenhauer serves on the executive steering committee of the Parkinson’s Progression Markers Initiative (PPMI) of The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and is co-chair of the Biologics Working Group of PPMI. She is on the Therapeutic Evaluation Committee of the “Path-to-Prevention Initiative” of MJFF and co-chair of the Basic Science Special Interest Group of the Movement Disorder Society.

She has been a principal investigator for several phase 2 and 3 clinical trials. Her research is focused on the detection of biomarkers in human body fluids and development of experimental techniques to improve the diagnosis of movement disorders. She has published more than 125 scientific articles in journals such as The Lancet Neurology, Neurology, Movement Disorders, and Brain and received since 2019 every year an award as a highly cited researcher worldwide by Web of Science.